logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Synchroneuron, Inc.


USPTO Granted Patents = 15

% Expired Patents = 13.3


Forward Citations = 372

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Barry S Fogel (15 out of 20 patents)

silverMedal William D Kerns (5 out of 5 patents)

bronzeMedal Kei-Lai Fong (5 out of 5 patents)

4.  San-Laung Chow (1 out of 7 patents)

5.  Edward Lin (1 out of 1 patent)

6.  David N Wong (1 out of 34 patents)

7.  Edward Lin (0 patent)


15 patents:

1. 10512621 - Methods of treating posttraumatic stress disorder with acamprosate salts (2019-12-24),
2. 10166207 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2019-01-01),
3. 9427420 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-30),
4. 9421179 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),
5. 9421178 - Acamprosate formulations, methods of using the same, and combinations comprising the same (2016-08-23),
6. 7745493 - Methods of treating tardive dyskinesia and other movement disorders (2010-06-29),
7. 7498361 - Methods of treating tardive dyskinesia and other movement disorders (2009-03-03),
8. 6689816 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2004-02-10),
9. 6391922 - Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders (2002-05-21),
10. 6294583 - Methods of treating tardive dyskinesia and other movement disorders (2001-09-25),
11. 6159944 - Method for treating painful conditions of the anal region and (2000-12-12),
12. 6117877 - Method for treating painful conditions of the anal region and (2000-09-12),
13. 6057373 - Methods of treating tardive dyskinesia and other movement disorders (2000-05-02),
14. 5952389 - Methods of treating tardive dyskinesia and other movement disorders (1999-09-14),
15. 5866585 - Methods of treating tardive dyskinesia using NMDA receptor antagonists (1999-02-02),
Company Overview
Synchroneuron, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapies for neurodegenerative diseases. The organization focuses on advancing treatments that target synaptic dysfunction, aiming to restore neural connectivity and improve patient outcomes. With a commitment to scientific excellence, Synchroneuron leverages cutting-edge research and technology to address unmet medical needs in the field of neurology, contributing to the broader landscape of therapeutic advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#169 in Cambridge, MA

#1,275 in Massachusetts

#21,046 in US

#39,906 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Synchroneuron, Inc.

Forward Citations = 372

6 inventors:

goldMedal Barry S Fogel (15 out of 20 patents)

silverMedal William D Kerns (5 out of 5 patents)

bronzeMedal Kei-Lai Fong (5 out of 5 patents)

4.  San-Laung Chow (1 out of 7 patents)

5.  Edward Lin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synchroneuron, Inc.. Retrieved from https://idiyas.com/company/synchroneuron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…